Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Everything to know about NASA's moon mission launching this week - 2What you need to know about flu treatments as cases spike across the US
- 3Factbox-Weight-loss drug developers line up to tap lucrative market as competition heats up
- 4Germany's first Omani LNG shipments arrive despite Middle East disruptions
- 5Jubilant FoodWorks to scrap Dunkin’ franchise arrangement in India
- The Electric Bicycle Americans Can Confide in 2024
- 4 Coolers for Present day Kitchens
- A Gastronomic Experience in Healthy Enjoyments: A Survey of \Nutritious and Tasty\ Solid Cooking Recipe Book
- 4 Family SUVs: Joining Solace and Style
- Audits of the Top Science fiction Movies This Year
- The Response Uncovered: Disentangling the Secrets of the Universe
- 5 Family SUVs for 2024: Which One Accommodates Your Family's Needs\uff1f
- Sunken warship found off Danish coast after 225 years in ‘remarkable’ discovery
- Millions in JDM Exports and Exotic Supercars Are Currently Trapped at Sea
